Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction von Wainberg, Z A, Lin, L-S, DiCarlo, B, Dao, K M, Patel, R, Park, D J, Wang, H-J, Elashoff, R, Ryba, N, Hecht, J R

Volltext

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefr... von Grothey, Axel, Strosberg, Jonathan R, Renfro, Lindsay A, Hurwitz, Herbert I, Marshall, John L, Safran, Howard, Guarino, Michael J, Kim, George P, Hecht, J R, Weil, Susan C, Heyburn, John, Wang, Wenquan, Schweizer, Charles, O'Shannessy, Daniel J, Diaz, Jr, Luis Alberto

Volltext

CT colonography: value of scanning in both the supine and prone positions von Chen, SC, Lu, DS, Hecht, JR, Kadell, BM

Volltext

Responses and durability of clinical benefit in pancreatic ductal adenocarcinoma (PDAC) patients treated with pegilodecakin (AM0010) in combination with 5-FU/LV and oxaliplatin (FO... von Hecht, J.R., Naing, A., Falchook, G.S., Patel, M.R., Aljumaily, R., Wong, D.J., Autio, K.A., Wainberg, Z.A., Javle, M., Bendell, J., Pant, S., Hung, A., Oft, M., Leveque, J., Papadopoulos, K.P.

Volltext

Immunohistochemical evaluation of K- ras, p53, and HER-2/ neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: Evidence for multistep carcinogenes... von Apple, Sophia K, Randolph Hecht, J, Lewin, David N, Jahromi, Soraya A, Grody, Wayne W, Nieberg, Roberta K

Volltext

Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases von Hecht, J.R., Raman, S.S., Chan, A., Kalinsky, K., Baurain, J.-F., Jimenez, M.M., Garcia, M.M., Berger, M.D., Lauer, U.M., Khattak, A., Carrato, A., Zhang, Y., Liu, K., Cha, E., Keegan, A., Bhatta, S., Strassburg, C.P., Roohullah, A.

Volltext

Low-dose trimetrexate glucuronate and protracted 5-fluorouracil infusion in previously untreated patients with advanced pancreatic cancer von Amado, R. G., Rosen, L. S., Hecht, J. R., Lin, L.-S., Rosen, P. J.

Volltext

PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previ... von SCHWARTZBERG, Lee S, RIVERA, Fernando, KARTHAUS, Meinolf, FASOLA, Gianpiero, CANON, Jean-Luc, HECHT, J. Randolph, HUA YU, OLINER, Kelly S, GO, William Y

Volltext

Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program von Lieu, Christopher H, Renfro, Lindsay A, de Gramont, Aimery, Meyers, Jeffrey P, Maughan, Timothy S, Seymour, Matthew T, Saltz, Leonard, Goldberg, Richard M, Sargent, Daniel J, Eckhardt, S Gail, Eng, Cathy

Volltext

Thermal properties of MoSi2 and SiC whisker-reinforced MoSi2 von BOSE, S, HECHT, R. J

Volltext

Processing and mechanical properties of niobium-reinforced MoSi2 composites von XIAO, L, KIM, Y. S, ABBASCHIAN, R, HECHT, R. J

Volltext

1143PResponses and durability of clinical benefit in pancreatic ductal adenocarcinoma (PDAC) patients treated with pegilodecakin (AM0010) in combination with 5-FU/LV and oxaliplati... von Hecht, J R, Naing, A, Falchook, G S, Patel, M R, Aljumaily, R, Wong, D J, Autio, K A, Wainberg, Z A, Javle, M, Bendell, J, Pant, S, Hung, A, Oft, M, Leveque, J, Papadopoulos, K P

Volltext

Interdependencia cleptocrática: Caso de estudio El Salvador von Gómez-Hecht, J. R, Juan Ricardo

Volltext

Adjuvant therapy for gastric cancer: a reality at last von Hecht, J R

Volltext

Prolonged nausea and vomiting after high dose chemotherapy and autologous peripheral stem cell transplantation in the treatment of high risk breast carcinoma von Hecht, J. Randolph, Lembo, Tony, Chap, Linnea

Volltext

Male breast cancer von Hecht, J R, Winchester, D J

Volltext

Clostridium difficile colitis secondary to intravenous vancomycin von HECHT, J. R, OLINGER, E. J

Volltext

SPIRITT: A multicenter, open-label, randomized, phase II clinical trial evaluating safety and efficacy of FOLFIRI with either panitumumab or bevacizumab as second-line treatment in... von Cohn, A. L., Krishnan, K., Hecht, J. R.

Volltext

Development of continuous-fiber-reinforced MoSi2-base composites von MALONEY, M. J, HECHT, R. J

Volltext

Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears von APPLE, S. K, HECHT, J. R, NOVAK, J. M, NIEBERG, R. K, ROSENTHAL, D. L, GRODY, W. W

Volltext